Categories
News | Displaying 1 - 10 of 88 results.
September 11, 2014

Read more here: http://www.allure.com/beauty-products/best-of-beauty/2014/best-of-beauty-skin-care#slide=11

September 10, 2014

Elure is mentioned in Allure Magazine's official Best of Beauty Press Release - see here

August 14, 2014

Syneron announced today the market launch of its proprietary handpiece featuring a new 5-millimeter spot size for the Gentle Pro Nd:YAG Laser Series. Read the press release HERE

July 28, 2014

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that its new PicoWay® device has received CE Mark indication to treat tattoos of all types and colors and pigmented lesions on any skin type. PicoWay is a new and innovative dual wavelength device, with 532nm and 1064nm wavelengths, which utilizes Syneron's proprietary PicoWay technology to deliver energy to the skin using pulses which are trillionths of a second, known as picosecond pulses. Syneron will begin a staged launch of the PicoWay device in the international market during the third quarter of 2014 and anticipates that it will receive U.S. Food and Drug Administration (FDA) clearance for PicoWay by the end of 2014. Read More

July 21, 2014

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it has received the China Food and Drug Administration (CFDA) clearance for its elure™ Advanced Skin Brightening Lotion. The elure skin brightening solution is a new cosmetic product originally available only from dermatologists, plastic surgeons and other medical aesthetic providers. Read More

April 29, 2014

Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that that its subsidiary in Japan, Candela KK, received registration approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market its ALEX II™ system in Japan for the treatment of benign dermal lesions. 

A special configuration of Candela's successful Alex TriVantage® platform that has been customized for the Japanese market, the ALEX II is a single wavelength Q-switched alexandrite laser designed to treat congenital pigmented lesions and tattoos. It is the second generation of the 755nm Q-switched laser system popular in Japan for the treatment of pigmented lesions common to Japanese skin types. It features 2mm, 3mm and 4mm treatment spot sizes and is capable of delivering up to 18 J/cm2 fluence. Read More
April 14, 2014

UltraShape® NOW! FDA cleared for abdominal circumference reduction by mechanical disruption of fat cells! read more in the official press release

April 08, 2014

Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that the Syneron Candela's leading products will be featured in presentations at LASER 2014, the 34th Annual Scientific Conference of the American Society for Laser Medicine and Surgery (ASLMS), April 2-6 in Phoenix, AZ. This includes an abstract presentation on body contouring with VelaShape III, which received the prestigious Dr. Richard E. Fitzpatrick Clinical Research and Innovations Award. The award was presented to study author Lori A. Brightman, M.D., Associate Adjunct Surgeon, Department of Plastic Surgery, New York Eye and Ear Infirmary. Read More

April 03, 2014

Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today that its proprietary Sublative™ technology has received CE Mark indication for the effective treatment of striae (stretch marks) and acne scars. The new treatment protocols are now available on all of the Syneron Sublative compatible systems, which include elōs Plus™eTwo™ and eMatrix™.

Stretch marks are one of the most common skin disorders, impacting 95% of women during puberty or pregnancy, and can also occur in men and children. Historically difficult to treat, striae occur when the skin is stretched from rapid growth or weight gain, and causes damage to the connective tissue in the dermis.

Acne is a common condition experienced by up to 85% of adolescents and young adults and 5% of older adults. In some patients, the healing process results in permanent, disfiguring scars. Treatments ranged from chemical peels to ablative procedures with long recovery times and risky side effects. Read More

March 21, 2014

Syneron Medical Ltd. (NASDAQ: ELOS), a global market leader in the aesthetic medical device marketplace, will showcase technology that shapes the future of aesthetics at the 72nd Annual Meeting of the American Academy of Dermatology (AAD) in Denver March 21-25, 2014.
A leading architect in the global aesthetics industry, Syneron Candela will launch its latest body shaping game changers, the award winning VelaShape® III and the Trio (from recently acquired New Star Lasers, Inc.) for laser assisted lipolysis, endovenous ablation of varicose veins and non-ablative skin rejuvenation. Read More

 

News | Displaying 1 - 10 of 88 results.

Learn more / Purchase options

For clinics and physicians: Fill in your details and we will contact you shortly.
Submit